The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1612
ISSUE 1612
November 30, 2020
Drugs for Acne
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
November 30, 2020 (Issue: 1612)
Acne is common among adolescents and young adults,
but its prevalence appears to have increased in people
of all ages due to prolonged wearing of masks during
the COVID-19 pandemic. Guidelines for treatment of
acne were last published in 2016.
... more
- S Giacalone et al. Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown. Clin Exp Dermatol 2020 July 13 (epub).
- AL Zaenglein et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945.
- Minocycline foam (Amzeeq) for acne. Med Lett Drugs Ther 2020; 62:68.
- Trifarotene (Aklief) – a new topical retinoid for acne. Med Lett Drugs Ther 2019; 61:195.
- A Hebert et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol 2020; 156:621.
- Sarecycline (Seysara) – another oral tetracycline for acne. Med Lett Drugs Ther 2019; 61:43.

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian